Company news

EKF Diagnostics Holdings plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Selah consideration update

November 6, 2015

Strategic Update

October 23, 2015

Extension to deadline under Rule 2.6(c)

October 19, 2015

PointMan used in liquid biopsy research study

October 15, 2015

Half Yearly Report

September 28, 2015

New data published on PointMan

September 18, 2015

New tender wins for Hemo Control

September 3, 2015

Withdrawal of non-binding proposal

August 26, 2015

Announcement under rule 2.4 of the Takeover Code

August 24, 2015

Conclusion of Strategic Review

August 18, 2015

Launch of PrecisionPath Colon

May 13, 2015

Data for PointMan Technology presented at AACR

April 21, 2015

Shareholder update

April 2, 2015

Collaboration to improve colon cancer treatment

March 2, 2015

Notice of results & investor results presentation

February 23, 2015

PointMan collaboration with ANGLE plc

January 23, 2015

Payment of DiaSpect's deferred consideration

January 5, 2015

Trading update & potential Board appointment

December 17, 2014

US collaboration to develop blood tests for cancer

September 23, 2014

Notice of results and investor briefing

August 13, 2014

Contract Win and Regulatory Approval

July 8, 2014

Grant of Share Options

June 9, 2014

Major step towards detecting cancer in blood

June 2, 2014

Selah to provide Women's Health testing services

May 20, 2014

Holding(s) in Company - Replacement

May 19, 2014

Selah update

May 7, 2014

Investor Teach-In

April 15, 2014

Results of General Meeting and Total Voting Rights

April 11, 2014

Result of Offer

April 10, 2014

Director Resignation

March 31, 2014

Holding(s) in Company Replacement

March 24, 2014

Result of the Placing

March 20, 2014

Acquisition of Separation Technology, Inc.

March 12, 2014

Transfer of production

March 4, 2014

Quo-Lab registration in Mexico

February 18, 2014

Additional Listing

January 28, 2014

Year end trading update

January 27, 2014

PointMan enriches low-level mutations from blood

January 20, 2014

Acute Kidney Injury marker development

November 19, 2013

New PointManT DNA enrichment products launched

November 4, 2013

Change of Registered Office

October 3, 2013

Investor Results Briefing

September 19, 2013

Interim Results

September 16, 2013

Senior management update

July 23, 2013

Analyst & Investor Teach-In

June 26, 2013

Director Share Transfer

June 18, 2013

Amendment to Long-Term Incentive Plan

June 11, 2013

First PointMan DNA enrichment products launched

May 13, 2013

Publication of Annual Report & Notice of AGM

April 15, 2013

Establishment of EKF Molecular & Acquisition

March 4, 2013

← Newer news releases · Older news releases →

Calls

The 5 newest of 13 calls. Every call is listed under its year.

Decks

The 5 newest of 28 decks. Every deck is listed under its year.